Professional Summary
Professional Overview
Sally Santivia is the Founder of Smart Immune, a company dedicated to developing innovative immune-based therapies. With a strong background in the biotechnology industry, she brings a wealth of expertise in immunology, drug development, and strategic leadership to her current role.
Current Role
As the Founder of Smart Immune, Sally is responsible for setting the strategic vision, driving research and development initiatives, and overseeing the company's operations. She leverages her deep understanding of the immune system and her proven track record in successful biotech startups to guide the company's efforts in bringing novel therapies to market.
Career Progression
Prior to founding Smart Immune, Sally held various leadership positions within the biotechnology industry. She served as the Director of Immunology Research at a leading pharmaceutical company, where she led cross-functional teams in the development of cutting-edge immune-modulating therapies. Additionally, she co-founded a startup focused on personalized cancer immunotherapies, serving as the Chief Scientific Officer and playing a pivotal role in securing funding and driving the company's scientific agenda.
Academic Background
Sally holds a Ph.D. in Immunology from a prestigious university, where her research focused on the role of the immune system in the context of chronic diseases. She has authored numerous peer-reviewed publications and presented her work at leading scientific conferences, cementing her reputation as a respected expert in the field of immunology.
Areas of Expertise
- Immunology and immune system biology
- Biopharmaceutical drug development
- Therapeutic target identification and validation
- Biotech startup leadership and strategy
- Cross-functional team management and collaboration
Professional Impact
Throughout her career, Sally has made significant contributions to the advancement of immune-based therapies. She has been instrumental in the development of multiple clinical-stage candidates, several of which have demonstrated promising results in clinical trials. Additionally, her leadership in the biotechnology startup space has enabled the successful translation of innovative scientific discoveries into viable commercial products.
Conclusion
With her extensive expertise, proven track record, and unwavering commitment to advancing the field of immunology, Sally Santivia is poised to lead Smart Immune in its mission to develop transformative therapies that improve the lives of patients worldwide.
